美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Defiance Daily Target 2X Long MRNA ETF

96.74

+13.4916.20%

成交量：26.51萬

成交額：2,582.12萬

市值：2,708.72萬

市盈率：- -

高：101.81

開：91.18

低：88.87

收：83.25

52周最高：143.84

52周最低：14.95

股本：28.00萬

流通股本：28.00萬

量比：6.04

換手率：94.68%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

阿斯利康股價盤後跌超2%，因其三期臨床試驗結果令人失望。

Moderna Inc(MRNA)股票9月11日盤中上漲8.63%：關鍵驅動因素揭曉

TradingKey中文

沃森生物(300142.SZ)子公司新型冠狀病毒mRNA疫苗獲得藥品註冊證書

沃森生物：玉溪沃森mRNA疫苗獲批上市許可，適用18周歲以上

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/MRNX"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"MRNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long MRNA ETF","latestPrice":96.74,"timestamp":1789657698852,"preClose":83.25,"halted":0,"volume":265096,"delay":0,"changeRate":0.16204204204204198,"floatShares":280000,"shares":280000,"eps":0,"marketStatus":"交易中","change":13.49,"latestTime":"09-17 11:08:20 EDT","open":91.175,"high":101.81,"low":88.87,"amount":25821172.1976,"amplitude":0.155435,"askPrice":96.75,"askSize":60,"bidPrice":96.44,"bidSize":60,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":83.25,"sharesOutstanding":30000,"nav":81.19,"aum":22733200,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":91.01,"preClose":83.25,"latestTime":"09:29 EDT","volume":9901,"amount":897502.77869,"timestamp":1789651799999,"change":7.76,"changeRate":0.093213,"amplitude":0.105345},"postHourTrading":{"tag":"盘后","latestPrice":84.14,"preClose":83.25,"latestTime":"19:59 EDT","volume":2364,"amount":197490.4251,"timestamp":1789603180978,"change":0.89,"changeRate":0.010691,"amplitude":0.028589},"volumeRatio":6.037355,"impliedVol":1.3503,"impliedVolPercentile":0.4375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNX\",,,,,undefined,":{"symbol":"MRNX","floatShares":280000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":6.037355,"shares":280000,"dividePrice":0,"high":101.81,"amplitude":0.155435,"preClose":83.25,"low":88.87,"week52Low":14.95,"pbRate":"--","week52High":143.84,"institutionHeld":0,"latestPrice":96.74,"eps":0,"divideRate":0,"volume":265096,"delay":0,"ttmEps":0,"open":91.175,"prevYearClose":20.61,"prevWeekClose":81.41,"prevMonthClose":79.5,"prevQuarterClose":42.65,"fiveDayClose":73.84,"twentyDayClose":141.64,"sixtyDayClose":32.862},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MRNX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MRNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MRNX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MRNX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666571008","title":"阿斯利康股價盤後跌超2%，因其三期臨床試驗結果令人失望。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571008","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666571008?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 04:23","pubTimestamp":1789158183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GNOM","SYNB","LU2322448791.USD","TMED","LFSC","HELX","LU1992135399.USD","PBE","BK4585","FTXH","BBH","CANC","LU2272731600.USD","LU2272731865.HKD","RSPH","PSCH","IBB","IDNA","IEIH","MRNY","XBIX","BK4588","FBT","BME","RXL","AZNH","LU2322448957.HKD","PJP","XPH","IEHS","LU2272731782.SGD","WDNA","IBRN","BIOY","LU2473716301.USD","IYH","MEDI","IE00B5TLWC47.USD","BBP","MRNX","LU1992135472.HKD","BIB","PPH","PBPH","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666657657","title":"Moderna Inc(MRNA)股票9月11日盤中上漲8.63%：關鍵驅動因素揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=2666657657","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666657657?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 01:16","pubTimestamp":1789146984,"startTime":"0","endTime":"0","summary":"• 受机构买盘重新涌入及盘整巩固的推动，莫德纳出现上行波动。\n• intismeran autogene 的 3 期临床试验结果验证了其肿瘤学平台。\n• 最新年度营收为 19.4 亿美元，净亏损为 28.2 亿美元。","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262164048-market-movers-mrna-20260911","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4501","BK4568","IDNA","BK4533","GNOM","WDNA","BK4139","MRNX","BK4588","MRNA","BK4532","BK4551","BK4585","MRNY","BK4534","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666596397","title":"沃森生物(300142.SZ)子公司新型冠狀病毒mRNA疫苗獲得藥品註冊證書","url":"https://stock-news.laohu8.com/highlight/detail?id=2666596397","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666596397?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 20:57","pubTimestamp":1789045066,"startTime":"0","endTime":"0","summary":"智通财经APP讯，沃森生物 发布公告，公司全资子公司玉溪沃森生物技术有限公司于2026年9月10日收到由国家药品监督管理局批准颁发的“新型冠状病毒mRNA疫苗”《药品注册证书》。据悉，该疫苗是公司基于mRNA平台技术策略迭代开发的第三代新冠病毒mRNA疫苗。目前，mRNA技术在全球正应用于生物医药前沿科技创新研发及应用领域。自2020年以来，公司对mRNA技术持续加大研发投入，建立了国内领先的mRNA技术和产业化平台。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1494658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","BK0077","MRNY","BK0070","MRNX","BK0239","300142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666989385","title":"沃森生物：玉溪沃森mRNA疫苗獲批上市許可，適用18周歲以上","url":"https://stock-news.laohu8.com/highlight/detail?id=2666989385","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666989385?lang=zh_tw&edition=fundamental","pubTime":"2026-09-10 19:48","pubTimestamp":1789040889,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS","MRNY","MRNX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MRNX\",params:#limit:6,delay:false,,,undefined,":[]}}